Inhibition of a lower potency target drives the anticancer activity of a clinical p38 inhibitorCell chemical biologyOctober 1, 202310.1016/j.chembiol.2023.09.013Cited by 24SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis